𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improvement in treatment results in SCLC with the addition of VP-16-213 to cyclophosphamide, adriamycin, and vincristine (CAV)

Book ID
123585952
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
179 KB
Volume
2
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Vincristine, adriamycin, cyclophosphamid
Vincristine, adriamycin, cyclophosphamide, and etoposide (VP16-213) in small-cell anaplastic carcinoma of the lung
✍ F. E. Eyben; Γ…. Arwidi; C. Hellekant; K. Jonsson; S. Γ…. Lindahl; W. Mattsson; L. πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 299 KB

Twelve patients with small-cell anaplastic carcinoma of the lung were treated with vincristine 1 mg/m2 i.v. day 1, adriamycin 50 mg/M2 i.v. day 1, cyclophosphamide 1,000 mg/m2 i.v. day 1, and etoposide 80 mg/m2 i.v. day 2, 4, 6 given on an outpatient basis and repeated at 3-week intervals. As consol

Chemotherapy combination with cyclophosp
Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL)
✍ J. M. Gracia; A. Jimenez πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 178 KB

Twenty-four evaluable patients with small cell carcinoma of the lung were treated with an escalating chemotherapy regimen including Cyclophosphamide, Adriamycin, Vincristine and VP16-213. The initial doses were CTX 800 mg/m2 i.v. day 1; ADR 50 mg/m2 i.v. day 1; VCR 1.4 mg/m2 day 1 weekly; and VP16-2

VP 16–213 and cyclophosphamide in the tr
VP 16–213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features
✍ Hurd, David D. ;Peterson, Bruce A. ;McKenna, Robert W. ;Bloomfield, Clara D. πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 281 KB

## Abstract The treatment of refractory acute nonlymphocytic leukemia remains a major clinical problem in leukemia therapy. VP 16–213 is an investigational agent that may have specificity for monocytic blasts, and the combination of VP 16–213 and cyclophosphamide is synergistic in experimental leuk